Omeros | Eigenkapital Und Reserven





Eigenkapital Und Reserven Veränderung Datum
Adma Biologics USD 431.19M 32.87M 2025-09
Alnylam Pharmaceuticals USD 233.89M 16.7M 2025-09
BioMarin Pharmaceutical USD 6.06B 29.6M 2025-09
Cytokinetics USD -521.12M 216.32M 2025-09
Dynavax Technologies USD 534.14M 39.98M 2025-09
Gilead Sciences USD 21.46B 1.78B 2025-09
Heron Therapeutics USD 14.88M 42.14M 2025-09
Immunic USD 10.5M 23.41M 2025-09
Insmed USD 945.57M 304.16M 2025-09
Knight Therapeutics CAD 773.91M 11.11M 2024-09
MacroGenics USD 67M 20.38M 2025-09
Omeros USD -228.68M 15.13M 2025-06
Pacira USD 727.21M 30.55M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
Rockwell Medical USD 30.41M 1.11M 2025-06
Sangamo BioSciences USD 19.6M 14.7M 2025-06
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
United Therapeutics USD 6.59B 583.4M 2025-09
Vertex Pharmaceuticals USD 17.32B 143.4M 2025-09
Xoma USD 87.94M 15.5M 2025-09


Omeros Eigenkapital Und Reserven - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.